GPS Wealth Strategies Group, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
GPS Wealth Strategies Group, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$19
-13.6%
500.0%0.00%
Q2 2023$22
-46.3%
500.0%0.00%
Q1 2023$41500.0%0.00%
Q3 2022$0500.0%0.00%
Q2 2022$0500.0%0.00%
Q1 2022$0500.0%0.00%
Q4 2021$0500.0%0.00%
Q3 2021$0
-100.0%
50
-79.9%
0.00%
-100.0%
Q2 2021$2,0000.0%2490.0%0.00%0.0%
Q1 2021$2,0002490.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders